Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
2.190
+0.290 (15.26%)
At close: Oct 6, 2025, 4:00 PM EDT
2.240
+0.050 (2.28%)
Pre-market: Oct 7, 2025, 4:12 AM EDT

Aytu BioPharma Income Statement

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2016 - 2020
66.3865.1873.896.6765.63
Upgrade
Revenue Growth (YoY)
1.84%-11.68%-23.66%47.29%137.52%
Upgrade
Cost of Revenue
20.5516.1321.5746.3936.43
Upgrade
Gross Profit
45.8349.0552.2350.2829.2
Upgrade
Selling, General & Admin
38.2942.0449.7769.8855.81
Upgrade
Research & Development
1.332.773.9812.665.62
Upgrade
Operating Expenses
43.2948.4957.4488.3967.44
Upgrade
Operating Income
2.540.57-5.21-38.1-38.24
Upgrade
Interest Expense
-3.7-5.06-5.15-0.01-0.01
Upgrade
Other Non Operating Income (Expenses)
-2.22-3.135.220.86-2.04
Upgrade
EBT Excluding Unusual Items
-3.38-7.63-5.14-37.26-40.29
Upgrade
Merger & Restructuring Charges
-2.1-2.16---7.81
Upgrade
Impairment of Goodwill
----65.8-
Upgrade
Asset Writedown
-8.26--2.73-7.66-12.83
Upgrade
Other Unusual Items
--0.590.581.822.89
Upgrade
Pretax Income
-13.75-10.38-7.29-108.89-58.03
Upgrade
Income Tax Expense
0.442.140.26-0.110.26
Upgrade
Earnings From Continuing Operations
-14.18-12.52-7.55-108.78-58.29
Upgrade
Earnings From Discontinued Operations
0.62-3.32-9.5--
Upgrade
Net Income
-13.56-15.84-17.05-108.78-58.29
Upgrade
Net Income to Common
-13.56-15.84-17.05-108.78-58.29
Upgrade
Shares Outstanding (Basic)
66311
Upgrade
Shares Outstanding (Diluted)
66311
Upgrade
Shares Change (YoY)
13.40%65.81%127.22%75.54%270.57%
Upgrade
EPS (Basic)
-2.16-2.86-5.11-74.01-69.61
Upgrade
EPS (Diluted)
-2.16-2.86-5.11-74.01-69.61
Upgrade
Free Cash Flow
-2.17-1.72-5.13-28.82-28.31
Upgrade
Free Cash Flow Per Share
-0.34-0.31-1.54-19.61-33.80
Upgrade
Gross Margin
69.04%75.26%70.77%52.02%44.49%
Upgrade
Operating Margin
3.82%0.87%-7.05%-39.42%-58.26%
Upgrade
Profit Margin
-20.43%-24.31%-23.11%-112.53%-88.81%
Upgrade
Free Cash Flow Margin
-3.26%-2.63%-6.95%-29.82%-43.13%
Upgrade
EBITDA
7.917.292.49-27.96-29.04
Upgrade
EBITDA Margin
11.92%11.18%3.38%-28.92%-44.25%
Upgrade
D&A For EBITDA
5.386.737.710.159.2
Upgrade
EBIT
2.540.57-5.21-38.1-38.24
Upgrade
EBIT Margin
3.82%0.87%-7.05%-39.42%-58.26%
Upgrade
Advertising Expenses
---13.615.2
Upgrade
Updated Sep 23, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q